Keurig Dr Pepper Gears Up for Q1 Earnings: Key Facts to Note
Werte in diesem Artikel
Keurig Dr Pepper Inc. KDP is scheduled to release first-quarter 2025 results on April 24, before market open. The company is expected to register top-line growth when it reports the quarterly results. The Zacks Consensus Estimate for quarterly revenues is pegged at $3.56 billion, indicating a 2.8% rise from the year-ago period’s number.The consensus estimate for KDP’s first-quarter earnings has remained unchanged in the past 30 days at 38 cents per share. The consensus mark for earnings per share remains flat on a year-over-year basis.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.In the last reported quarter, the company delivered an earnings surprise of 1.8%. KDP has registered an earnings surprise of 3.4%, on average, in the trailing four quarters.Key Factors to Note Ahead of KDP’s Q1 ResultsContinued strength in brands and pricing actions have been bolstering the company’s perdormance. Its expansion initiatives and efforts to bring innovation to its products are acting as tailwinds. Sturdy momentum in the Refreshment Beverages segment has been contributing to its overall results. Contribution from the GHOST acquisition is likely to aid results.The Refreshment Beverages segment has been benefiting from innovations, effective in-market execution, growth in CSDs and expansion in energy and sports hydration. The International unit is also performing well. KDP is focused on reinforcing Electrolit’s distribution and improving away-from-home coffee, which are likely to drive results. Such traits, along with KDP’s consumer-focused innovation model, supported by comprehensive scorecards tracking awareness, household penetration and loyalty, are expected to have driven continued market share gains in the to-be-reported quarter. The Zacks Consensus Estimate for Refreshment Beverages unit sales is pegged at $2.2 billion, up 4.8% year over year.Although the aforesaid positives are likely to aid the quarterly results, Keurig Dr Pepper has been witnessing inflationary pressures and elevated selling, general and administrative (SG&A) costs, including increased marketing investments. The company has also been grappling with a sluggish Coffee segment for a while now. Lower volumes, unfavorable net price realization and declines in Brewer shipments have been weighing on the segment’s performance. The Zacks Consensus Estimate for the Coffee unit sales is pegged at $885 million, down 2.9% year over year.Valuation Picture From a valuation perspective, Keurig Dr Pepper stock is trading at a discount relative to historical and industry benchmarks. With a forward 12-month price-to-earnings ratio of 17.09x, which is below the five-year high of 23.33x and the Beverages - Soft Drinks industry’s average of 19.04x, the stock offers compelling value for investors seeking exposure to the sector.The recent market movements show that KDP’s shares have risen 12.7% in the past three months compared with the industry's growth of 11.9%.What the Zacks Model UnveilsOur proven model does not conclusively predict an earnings beat for Keurig Dr Pepper this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.Keurig Dr Pepper, Inc Price and EPS Surprise Keurig Dr Pepper, Inc price-eps-surprise | Keurig Dr Pepper, Inc QuoteKeurig Dr Pepper currently has an Earnings ESP of -0.90% and a Zacks Rank of 3.Stocks With the Favorable CombinationHere are some companies, which according to our model, have the right combination of elements to beat on earnings this reporting cycle.Freshpet FRPT currently has an Earnings ESP of +2.56% and a Zacks Rank of 3. The company is likely to register a decline in the top line when it reports first-quarter 2025 numbers. The consensus mark for revenues is pegged at $262.3 million, which indicates a drop of 17.2% from the figure reported in the year-ago quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Freshpet’s quarterly earnings per share of 13 cents implies a 38.1% decrease from the year-ago quarter. The consensus mark has fallen 23.5% in the past seven days. FRPT has a trailing four-quarter earnings surprise of 78.8%, on average.Church & Dwight Co. CHD has an Earnings ESP of +0.66% and a Zacks Rank of 3 at present. CHD is likely to register top-line growth when it releases first-quarter 2025 results. The Zacks Consensus Estimate for its quarterly revenues is pegged at $1.51 billion, which implies growth of 0.6% from the figure reported in the year-ago quarter.The consensus estimate for Church & Dwight’s quarterly earnings has remained unchanged in the past 30 days at 89 cents per share, implying a decline of 7.3% from the year-ago quarter’s number. CHD delivered an earnings surprise of 9.6%, on average, in the trailing four quarters.Hershey HSY currently has an Earnings ESP of +0.10% and a Zacks Rank of 3. HSY is anticipated to register top and bottom-line decline when it reports first-quarter 2025 results. The Zacks Consensus Estimate for Hershey’s quarterly revenues is pegged at $2.82 billion, indicating drop of 13.3% from the figure reported in the year-ago quarter. The consensus estimate for Hershey’s earnings has increased a penny in the past seven days to $1.94 per share. The consensus estimate implies a plunge of 36.8% from the year-ago quarter’s figure. HSY has delivered an earnings beat of 1.7%, on average, in the trailing four quarters.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hershey Company (The) (HSY): Free Stock Analysis Report Church & Dwight Co., Inc. (CHD): Free Stock Analysis Report Freshpet, Inc. (FRPT): Free Stock Analysis Report Keurig Dr Pepper, Inc (KDP): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Keurig Dr Pepper und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Keurig Dr Pepper
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Keurig Dr Pepper
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Keurig Dr Pepper Inc Registered Shs
Analysen zu Keurig Dr Pepper Inc Registered Shs
Datum | Rating | Analyst | |
---|---|---|---|
17.06.2019 | Dr Pepper Snapple Group Outperform | BMO Capital Markets | |
11.07.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.06.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.03.2018 | Dr Pepper Snapple Group Outperform | RBC Capital Markets | |
14.03.2018 | Dr Pepper Snapple Group Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
17.06.2019 | Dr Pepper Snapple Group Outperform | BMO Capital Markets | |
11.07.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.06.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.03.2018 | Dr Pepper Snapple Group Outperform | RBC Capital Markets | |
14.03.2018 | Dr Pepper Snapple Group Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
28.07.2017 | Dr Pepper Snapple Group Neutral | UBS AG | |
09.01.2017 | Dr Pepper Snapple Group Equal Weight | Barclays Capital | |
28.10.2016 | Dr Pepper Snapple Group Neutral | UBS AG | |
28.04.2016 | Dr Pepper Snapple Group Neutral | UBS AG | |
27.10.2015 | Dr Pepper Snapple Group Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
01.12.2014 | Dr Pepper Snapple Group Underperform | RBC Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Keurig Dr Pepper Inc Registered Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen